Skip to search formSkip to main contentSkip to account menu

EPHA5 gene

Known as: EPH Receptor A5 Gene, BSK, MOUSE, HOMOLOG OF, EHK1 
This gene is involved in brain development.
National Institutes of Health

Related topics

Related topics

11 relations
Cellular TropismEPHA3 geneEPHA3 wt AlleleEPHA5 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
c-Fos downregulation positively regulates EphA5 expression in a congenital hypothyroidism rat model
The EphA5 receptor is well established as an axon guidance molecule during neural system development and plays an important role… 
2017
2017
Tbx5 is a novel transcriptional regulator of the EphA5 promoter
2017
2017
Molecular profiling of cancer outliers.
e13025Background: A few patients with metastatic cancer survive exceptionally longer than others under the same treatment. We… 
2015
2015
Downregulation of EphA5 by promoter methylation in human prostate cancer
EphA5 is a member of the Eph/ephrin family and plays a critical role in the regulation of carcinogenesis. A significant reduction… 
2015
2015
Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel—Letter
We have with great interest read the pharmacogenetic study by Abraham and colleagues ([1][1]) reporting SNPs associated with… 
2013
2013
Abstract LB-196: Sequencing symptom control: Results from the Alliance N08C1 and N08CA genetics of chemotherapy neuropathy trials.
Introduction: Symptom control is an important objective in the care of patients with cancer and a critical goal for long-term… 
2013
2013
After repeated division, bone marrow stromal cells express inhibitory factors with osteogenic capabilities, and EphA5 is a primary candidate
2010
2010
Inherited genetic variation in EPHA5, FGD4, and NRDG1 and paclitaxel (P)-induced peripheral neuropathy (PN): Results from a genome-wide association study (GWAS) in CALGB 40101.
3021 Background: CALGB 40101 is an ongoing phase III trial comparing the efficacy of standard therapy cyclophosphamide and… 
2007
2007
Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.
The Eph (erythroprotein-producing hepatoma amplified sequence) family receptor tyrosine kinases and their ephrin ligands (ephrins… 
2005
2005
[Preparation and analysis of monoclonal antibody against EphA4 peptide].
OBJECTIVE To prepare monoclonal antibody (MAb) against carboxy-terminus of E-phA4 and to analyze the immunological… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)